Japan's GHIT invests $6.8 M in product development for Malaria, NTDs and Ebola BioSpectrum AsiaGlobal Health Innovative Technology Fund Grants ¥1.06B to Nine Diagnostics, Vaccine R&D Projects GenomeWebTotal Investment of Approx. USD 6.8 Million in Product Development for Malaria, NTDs and Other Emerging & Re-emerging Infectious Diseases Such as Ebola Disease Yahoo Finance
Japan's GHIT invests $6.8 M in product development for Malaria, NTDs and Ebola BioSpectrum AsiaGlobal Health Innovative Technology Fund Grants ¥1.06B to Nine Diagnostics, Vaccine R&D Projects GenomeWebTotal Investment of Approx. USD 6.8 Million in Product Development for Malaria, NTDs and Other Emerging & Re-emerging Infectious Diseases Such as Ebola Disease Yahoo Finance
